Maike Pharmaceutical-B (02335): Research on XTL6001 accepted for presentation at EASD 2026 and ASN Kidney Week 2026

Medicure-B (02335) announced that research findings on one of its key products, XTL6001, have been accepted for presentation at several prestigious international academic conferences in the fields of diabetes, metabolic disorders, and nephrology. Following the initial report at the ADA Scientific Sessions, further analyses will be presented at the upcoming EASD and ASN annual meetings.

Zhitong FinanceAug 17 18:40

麥科醫藥-B：董事會會議召開日期

HKEXAug 14 21:44 · Announcements

HK Stock Market Movement | Medx Holdings-B (02335) Rises Over 3% as Preclinical and Phase I Clinical Data for MT200605 Accepted for Oral Presentation at WSC 2026

Medicilon-B (02335.HK) rose more than 3%. As of the time of writing, it was up 3.17% at HK$29.94, with a trading volume of HK$6.3033 million.

Zhitong FinanceAug 11 11:39

Medicilon-B (02335.HK): Preclinical and Phase I clinical data for MT200605 accepted for oral presentation at the 18th World Stroke Congress in 2026

Gelonghui, August 10 — Medkey Pharma-B (02335.HK) announced that preclinical and Phase I clinical data for MT200605, the Group’s internally developed intravenous neuroprotective candidate drug for the treatment of acute ischemic stroke (AIS), have been accepted for an oral presentation at the 18th World Stroke Congress 2026 ("WSC2026"). MT200605 is an intravenous neuroprotectant with a dual synergistic mechanism of action. To the Company’s knowledge, MT200605 is the only agent globally capable of crossing the blood-brain barrier ("

Gelonghui FinanceAug 10 22:51

HK Stock Market Movement | MedKey Pharma-B (02335) rises over 3% as MT200605 Phase II clinical trial for acute ischemic stroke meets primary endpoint

Medicino Group-B (02335.HK) rose more than 3%. As of this writing, it was up 3.4% at HK$30.40, with a trading volume of HK$20.4952 million.

Zhitong FinanceAug 4 14:38

Micot Pharma Gets Topline Results From AIS Drug Candidate Study; Shares Jump 3%

MT NewswiresAug 4 14:27